The stock market indices had another wild session, first gapping up and running to retest the highs, unable to get there, and by midday hit their peak on the Nasdaq 100. The S&P 500 did make a higher high in the afternoon, unconfirmed by the Nasdaq 100. That caused a negative divergence, which sold them off in the last hour.

Net on the day, the Dow was up 112.58 at 18,281.03, 34 points off its high. The S&P 500 was up 9.24 at 2159.73, 4 points off its high. The Nasdaq 100 was up 18.28 at 4877.75, 14 points off its high.

Advance-declines were 3 to 2 positive on the New York Stock Exchange, and 2 to 1 positive on the Nasdaq. Up/down volume was 2 1/2 to 1 positive on New York, total volume of 3.8 billion shares traded. The Nasdaq traded 2 billion shares and had a 11 to 6 positive volume ratio.

TheTechTrader.com board was mostly higher. Priceline.com (PCLN) was up 8.56 to 1497.58, Google Inc. (GOOG) up just 4 cents to 776.47, Apple Inc. (AAPL) also up just a few pennies, 5 cents to 113.05, Amazon.com Inc. (AMZN), reaching a new high, up 10.33 to 844.36, and Netflix, Inc. (NFLX) 3.94 to 106.28.

Baidu, Inc. (BIDU) gained 3 cents to 184.11, Facebook, Inc. (FB) popped 28 cents to 128.46 and First Solar, Inc. (FSLR), in a very strong solar sector today, jumped 1.53 to 39.74.

Tesla Motors, Inc. (TSLA) lost 2.95 to 208.46.

Other gainers of note included Acacia Communications, Inc. (ACIA), on an upgraded guidance, exploded 11.54, or 11%, to 113.54. That was a nice gain there. Puma Biotechnology, Inc. (PBYI) ran 3.09 to 65.63, Clovis Oncology Inc (CLVS), on takeover rumors, up 2.52 to 37.28, and Cara Therapeutics Inc. (CARA), had a very solid day, 1.03 to 9.68.

Biotech’s were generally firm. The Direxion Daily S&P Biotech Bull 3X ETF (LABU) ran 2.24 to 49.88.

On the downside, NOVAN, INC. (NOVN) gave back 1.24 to 18.90, and NUTANIX, INC. (NTNX) dropped 1.91 to 36.18.

Checking TheTechTrader.com percent-gain leaderboard, Aurinia Pharmaceuticals Inc. (AUPH) bounced 55 cents, or 16%, to 4.05, on 9.9 million shares traded.

Corbus Pharmaceuticals Holdings, Inc. (CRBP) advanced 1.85, or 26%, to 8.87, on 13.4 million shares traded, reaching as high as 9.75.

Net 1 Ueps Technologies Inc. (UEPS) climbed 2.00, or 22%, to 11.00, on 2.6 million shares traded. Resolute Energy Corporation (REN) closed up 5.02, or 20%, to 30.70, on 5.2 million shares traded. BioTelemetry, Inc. (BEAT) popped 2.42, or 13%, to 20.75, 1.8 million shares traded.

Stepping back and reviewing the hourly chart patterns, the indices started the day out with a gap up and a strong run early on, they pulled back very hard in the morning, and got to session highs on the Nasdaq 100 just before noon. At that point, the S&P 500 made a higher high. In the afternoon, they consolidated in wedges, tried to break out late, the S&P 500 actually making a new high at 2164, but the Nasdaq 100 couldn’t confirm, and in the last hour they pulled back to close positive on the day.

Good Trading!

Harry

For more of Harry Boxer, sign up for a FREE 15-Day Trial to his Real-Time Technical Trading Diary. Or sign up for a Free 30-Day Trial to his Top Charts of the Week service.

(c) 2016 AdviceTrade, Inc. All rights reserved. Distributed only by written permission of AdviceTrade and The Technical Trader at info@advicetrade.com . In using any portion of Harry Boxer's content, you agree to the terms and conditions governing the use of the service as described in our disclaimer at http://www.thetechtrader.com

Mr. Boxer's commentaries and index analysis represent his own opinions and should not be relied upon for purposes of effecting securities transactions or other investing strategies, nor should they be construed as an offer or solicitation of an offer to sell or buy any security. You should not interpret Mr. Boxer's opinions as constituting investment advice. Trades mentioned on the site are hypothetical, not actual, positions.

Harry Boxer Archive

Only logged in users are allowed to post comments. Register/ Log in

The Market Oracle is a FREE Financial Markets Forecasting & Analysis web-site.
(c) 2005-2024 MarketOracle.co.uk (Market Oracle Ltd) - Market Oracle Ltd asserts copyright on all articles authored by our editorial team and all comments posted. Any and all information provided within the web-site, is for general information purposes only and Market Oracle Ltd do not warrant the accuracy, timeliness or suitability of any information provided on this site. nor is or shall be deemed to constitute, financial or any other advice or recommendation by us. and are also not meant to be investment advice or solicitation or recommendation to establish market positions. We do not give investment advice and our comments are an expression of opinion only and should not be construed in any manner whatsoever as recommendations to enter into a market position either stock, option, futures contract, bonds, commodity or any other financial instrument at any time. We recommend that independent professional advice is obtained before you make any investment or trading decisions. By using this site you agree to this sites Terms of Use. From time to time we promote or endorse certain products / services that we believe are worthy of your time and attention. In return for that endorsement and only in the cases where you purchase directly though us may we be compensated by the producers of those products.